Novartis Korea Executives Indicted for Bribing Doctors

Mary Jane Wilmoth

Published On: August 10th, 2016

August 9, 2016. Pharmalot reports that six former and current Novartis executives at its Korean unit were indicted Monday on charges of paying doctors in return for prescribing its medicines. Read the full article.

Latest News & Insights

September 20, 2017
President Trump Calls on UN to Protect Whistleblowers
September 19, 2017
SEC Whistleblower Awards List July 2016
September 8, 2017
DeVos Pick Puts at Risk Veterans and Whistleblowers at For-Profit Colleges
August 16, 2017
GOVEXEC: A Whistleblower’s Guide for the Trump Era

New Release

Rules for Whistleblowers

The ultimate guide to blowing the whistle and getting rewarded for doing what's right.

Order Your Copy

Subscribe for News & Resources

Receive exclusive updates and news from our firm.

SEC Releases Financial Report Confirming the Unprecedented Success of its Whistleblower Program

SEC Whistleblower Program Announces Record Year In Annual Report to Congress

False Claims Act Whistleblower Wins Key Materiality Victory

Novartis Korea Executives Indicted for Bribing Doctors

Latest News & Insights

Rules for Whistleblowers

Subscribe for News & Resources

Subscribe to our newsletter to receive whistleblower news and resources crafted by the partners and associates at KKC.